Cargando…
Single dose of BNT162b2 mRNA vaccine against SARS-CoV-2 induces high frequency of neutralising antibody and polyfunctional T-cell responses in patients with myeloproliferative neoplasms
Autores principales: | Harrington, Patrick, de Lavallade, Hugues, Doores, Katie J., O’Reilly, Amy, Seow, Jeffrey, Graham, Carl, Lechmere, Thomas, Radia, Deepti, Dillon, Richard, Shanmugharaj, Yogita, Espehana, Andreas, Woodley, Claire, Saunders, Jamie, Curto-Garcia, Natalia, O’Sullivan, Jennifer, Raj, Kavita, Kordasti, Shahram, Malim, Michael H., Harrison, Claire N., McLornan, Donal P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8140572/ https://www.ncbi.nlm.nih.gov/pubmed/34023850 http://dx.doi.org/10.1038/s41375-021-01300-7 |
Ejemplares similares
-
Single dose of BNT162b2 mRNA vaccine against severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2) induces neutralising antibody and polyfunctional T‐cell responses in patients with chronic myeloid leukaemia
por: Harrington, Patrick, et al.
Publicado: (2021) -
Repeated vaccination against SARS-CoV-2 elicits robust polyfunctional T cell response in allogeneic stem cell transplantation recipients
por: Harrington, Patrick, et al.
Publicado: (2021) -
Repeated vaccination against SARS-CoV-2 elicits robust polyfunctional T cell response in allogeneic stem cell transplantation recipients
por: Harrington, Patrick, et al.
Publicado: (2021) -
Impaired humoral and T cell response to vaccination against SARS-CoV-2 in chronic myeloproliferative neoplasm patients treated with ruxolitinib
por: Harrington, Patrick, et al.
Publicado: (2022) -
P990: T CELL RESPONSE AND OMICRON VARIANT NEUTRALISATION FOLLOWING VACCINATION AGAINST SARS-COV-2 IN PATIENTS WITH CHRONIC MYELOID DISORDERS
por: Harrington, P., et al.
Publicado: (2022)